Systematic review literature on the effectiveness of the medicinal substances for targeted treatment of the renal cell cancer

Nowadays, malignant tumors are the second leading cause of death all over the world. Among malignant tumors of the kidney, renal cell cancer accounts for 90%. According to statistic information, stage 2 and 3 of the kidney cancer is more common among patients with this disease. Every year, 403.3 thousand new cases of kidney cancer are revealed in the world and this index is 2-3% of all epithelial malignant tumors.

Перевод пока недоступен